X hits on this document

102 views

0 shares

0 downloads

0 comments

25 / 30

April 2006

A Phase III Randomized, Open-Label, International Study Comparing Lapatinib and Capecitabine vs. Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer (EGF100151)

Study Enrollment Terminated due to Positive Interim Analysis

Document info
Document views102
Page views102
Page last viewedSat Dec 10 09:45:36 UTC 2016
Pages30
Paragraphs319
Words1235

Comments